Immuron (IMRN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.98, -4.65% vs the prior close of $1.03.
- Volume 21.30K shares, 0.0x its 50-day average (light).
- New SEC filings: 6-K (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
IMRN slides 4.7% to $0.98, a 3-month low, 6 down days in a row. Closed at $0.98, -4.65% vs the prior close of $1.03. Day range $0.95–$1.04, opened at $1.04.
IMRN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — IMRN slides 4.7% to $0.98, a 3-month low, 6 down days in a row
- Closed at $0.98, -4.65% vs the prior close of $1.03. Day range $0.95–$1.04, opened at $1.04.
- Volume was 21.30K shares, 0.0x its 50-day average of 2.64M — lighter than usual.
- Price is -17.4% vs its 50-day average ($1.19) and -3.1% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 18% of that range, 58.9% below the 52-week high.
- That makes 6 straight losses.
Oct 15, 2026 — IMRN ends flat (+0.0%) to $1.03, 5 down days in a row
- Closed at $1.03, +0.00% vs the prior close of $1.03. Day range $0.99–$1.04, opened at $1.04.
- Volume was 26.40K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -13.6% vs its 50-day average ($1.19) and +1.8% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 21% of that range, 56.9% below the 52-week high.
- That makes 5 straight losses.
Oct 14, 2026 — IMRN dips 1.0% to $1.03, a 3-month low, 4 down days in a row
- Closed at $1.03, -0.96% vs the prior close of $1.04. Day range $1.01–$1.07, opened at $1.05.
- Volume was 26.50K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -13.7% vs its 50-day average ($1.19) and +1.9% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 21% of that range, 56.9% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — IMRN ends flat (+0.0%) to $1.04, 3 down days in a row
- Closed at $1.04, +0.00% vs the prior close of $1.04. Day range $1.00–$1.10, opened at $1.01.
- Volume was 196.60K shares, 0.1x its 50-day average of 2.63M — lighter than usual.
- Price is -12.9% vs its 50-day average ($1.19) and +2.9% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 21% of that range, 56.5% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 6-K.
Oct 12, 2026 — IMRN slides 3.7% to $1.04, a 1-month low
- Closed at $1.04, -3.70% vs the prior close of $1.08. Day range $1.02–$1.06, opened at $1.05.
- Volume was 22.80K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -12.9% vs its 50-day average ($1.19) and +3.0% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 21% of that range, 56.5% below the 52-week high.
Oct 9, 2026 — IMRN dips 2.7% to $1.08
- Closed at $1.08, -2.70% vs the prior close of $1.11. Day range $1.07–$1.11, opened at $1.09.
- Volume was 10.60K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -9.7% vs its 50-day average ($1.20) and +7.1% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 24% of that range, 54.8% below the 52-week high.
Oct 8, 2026 — IMRN rises 1.8% to $1.11, 3 up days in a row
- Closed at $1.11, +1.83% vs the prior close of $1.09. Day range $1.09–$1.17, opened at $1.10.
- Volume was 34.20K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -7.2% vs its 50-day average ($1.20) and +10.1% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 25% of that range, 53.6% below the 52-week high.
- That makes 3 straight gains.
Oct 7, 2026 — IMRN rises 0.9% to $1.09
- Closed at $1.09, +0.93% vs the prior close of $1.08. Day range $1.05–$1.15, opened at $1.05.
- Volume was 40.60K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -8.8% vs its 50-day average ($1.20) and +8.2% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 24% of that range, 54.4% below the 52-week high.
Oct 6, 2026 — IMRN rises 0.9% to $1.08
- Closed at $1.08, +0.93% vs the prior close of $1.07. Day range $1.05–$1.11, opened at $1.08.
- Volume was 11.50K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -9.7% vs its 50-day average ($1.20) and +7.3% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 24% of that range, 54.8% below the 52-week high.
Oct 5, 2026 — IMRN dips 1.8% to $1.07, a 1-month low, 4 down days in a row
- Closed at $1.07, -1.83% vs the prior close of $1.09. Day range $1.05–$1.10, opened at $1.08.
- Volume was 37.80K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -10.5% vs its 50-day average ($1.20) and +6.4% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 23% of that range, 55.2% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 — IMRN slides 3.5% to $1.09, a 1-month low, 3 down days in a row
- Closed at $1.09, -3.54% vs the prior close of $1.13. Day range $1.08–$1.13, opened at $1.12.
- Volume was 88.80K shares, 0.0x its 50-day average of 2.63M — lighter than usual.
- Price is -8.9% vs its 50-day average ($1.20) and +8.4% vs its 200-day average ($1.01).
- 52-week range $0.68–$2.39; today's close sits at 24% of that range, 54.4% below the 52-week high.
- That makes 3 straight losses.
IMRN latest news & SEC filings
Every SEC filing by or about IMRN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 24, 2026 · Form 20-F — Annual report from a foreign company (20-F)
Annual report from a foreign company (20-F)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Sep 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 19, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 20, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade IMRN
- How much it moves: over the last 20 sessions the average daily move was 2.13% (largest 6.8%).
- Liquidity: about 70.46K shares (≈$69.20K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.98 vs a range of $0.68–$2.39 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 16, 2026; 6-K Oct 13, 2026; 20-F Sep 24, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
IMRN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.04 | 1.04 | 0.95 | 0.98 | 21.30K |
| Oct 15, 2026 | 1.04 | 1.04 | 0.99 | 1.03 | 26.40K |
| Oct 14, 2026 | 1.05 | 1.07 | 1.01 | 1.03 | 26.50K |
| Oct 13, 2026 | 1.01 | 1.10 | 1.00 | 1.04 | 196.60K |
| Oct 12, 2026 | 1.05 | 1.06 | 1.02 | 1.04 | 22.80K |
| Oct 9, 2026 | 1.09 | 1.11 | 1.07 | 1.08 | 10.60K |
| Oct 8, 2026 | 1.10 | 1.17 | 1.09 | 1.11 | 34.20K |
| Oct 7, 2026 | 1.05 | 1.15 | 1.05 | 1.09 | 40.60K |
| Oct 6, 2026 | 1.08 | 1.11 | 1.05 | 1.08 | 11.50K |
| Oct 5, 2026 | 1.08 | 1.10 | 1.05 | 1.07 | 37.80K |
| Oct 2, 2026 | 1.12 | 1.13 | 1.08 | 1.09 | 88.80K |
| Oct 1, 2026 | 1.14 | 1.18 | 1.12 | 1.13 | 53.40K |
| Sep 30, 2026 | 1.18 | 1.18 | 1.15 | 1.16 | 81.80K |
| Sep 29, 2026 | 1.14 | 1.23 | 1.14 | 1.19 | 186.30K |
| Sep 28, 2026 | 1.16 | 1.18 | 1.14 | 1.16 | 38.20K |
| Sep 25, 2026 | 1.16 | 1.22 | 1.16 | 1.16 | 43.90K |
| Sep 24, 2026 | 1.17 | 1.24 | 1.17 | 1.19 | 60.20K |
| Sep 23, 2026 | 1.26 | 1.26 | 1.16 | 1.17 | 105.70K |
| Sep 22, 2026 | 1.27 | 1.28 | 1.18 | 1.25 | 176.20K |
| Sep 21, 2026 | 1.22 | 1.30 | 1.19 | 1.24 | 146.40K |
About Immuron
Immuron (IMRN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CARLTON, VICTORIA, Australia. State of incorporation: Australia. Fiscal year ends June 30. SEC CIK 1660046.
IMRN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Paul Gerard Brennan | Chairman of the Board | May 4, 2026 |
| Jeannette Anne Joughin | Director | Apr 29, 2026 |
| Daniel Jude Pollock | Director | May 14, 2026 |
| Ravi Savarirayan | Director | Apr 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul Gerard Brennan | Chairman of the Board | May 4, 2026 |
| Jerry Kanellos | Chief Scientific Officer | Apr 29, 2026 |
| Aaron James Laurita | Chief Financial Officer | Apr 29, 2026 |
| Steven George Lydeamore | Chief Executive Officer | Apr 29, 2026 |
| Flavio Palumbo | Chief Commercial Officer | May 14, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
IMRN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
IMRN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on IMRN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.